TBPH

THERAVANCE BIOPHARMA INC

TBPH·G8807B106·US·Common Stock·Healthcare - Biotechnology-Activist

TBPH (THERAVANCE BIOPHARMA INC) is held by 108 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($69.7M), VANGUARD CAPITAL MANAGEMENT LLC ($29M), STATE STREET CORP ($21.1M). Net institutional sentiment: Mixed.

108
Holders
(7 Elite)
$351.8M
Total Value
63% (109)
Consensus
69 buying - 40 selling
13F: Insider & Congress:
TBPH

Smart Money Verdict

View all
Held by 108 funds
7 elite

Who's Trading

ActivistWAWeiss Asset Management LP14.5%Mar 25, 2026
InsiderFRFarnum RhondaSell $108KMar 16, 2026
InsiderFRFarnum RhondaSell $217KMar 16, 2026
InsiderFRFarnum RhondaSell $108KMar 16, 2026
ActivistNENewtyn Management, LLC8.5%Feb 17, 2026
InsiderFRFarnum RhondaSell $146KDec 3, 2025
InsiderFRFarnum RhondaSell $146KDec 3, 2025
InsiderFRFarnum RhondaSell $291KDec 3, 2025
InsiderBEBROSHY ERANSell $280KNov 26, 2025
CongressGeorge WhitesidesGeorge WhitesidesSale $15,001 - $50,000Mar 24, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.3M(+6.1%)$69.7M0.0%+69.18%
31
New
1.8M$29M0.0%+21.20%
40
Increased
1.3M(+17.7%)$21.1M0.0%+41.76%
33
Increased
1.3M(+134.2%)$20.4M0.0%+11.28%
46
Increased
1.1M(+21.2%)$18.5M0.0%+4.24%
34
Increased
983,615(+14.5%)$16M0.0%+52.25%
32
Decreased
954,042(-24.3%)$15.5M0.0%+54.93%
0
Increased
764,105(+34.0%)$12.4M0.0%+40.66%
36
Decreased
510,272(-36.5%)$8.3M0.0%+40.56%
0
Increased
416,143(+43.1%)$6.8M0.0%+38.02%
37
Increased
409,435(+130.1%)$6.6M0.0%+8.64%
44
Increased
404,147$6.6M0.0%+18.78%
27
New
400,759$6.5M0.0%+21.20%
38
Decreased
378,978(-5.4%)$6.2M0.0%-3.24%
0
Increased
370,534(+12.3%)$6M0.0%-10.94%
30
Increased
341,579(+1460.0%)$5.5M0.0%+23.52%
44
Decreased
327,546(-66.0%)$5.3M0.0%+8.95%
0
Decreased
310,594(-0.9%)$5M0.0%-2.93%
0
Decreased
289,473(-38.9%)$4.7M0.0%+12.48%
0
New
262,073$4.3M0.0%+21.20%
37

Showing 1-20 of 119

1 / 6
TBPHTBPHTHERAVANCE BIOPHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used